John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 98,980 shares at $246.03 ($24.6M) on 2025-03-07, disclosed to the SEC on 2025-03-07.
Seasonal sale ($24.6M) by Chief Executive Officer — this insider has traded BGNE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $246.03 | 1,400 | $344K | 1.4% |
| 2 | $246.10 | 2,100 | $517K | 2.1% |
| 3 | $246.69 | 1,190 | $294K | 1.2% |
| 4 | $246.69 | 1,190 | $294K | 1.2% |
| 5 | $246.91 | 13,918 | $3.4M | 13.9% |
| 6 | $246.91 | 13,918 |
| $3.4M |
| 13.9% |
| 7 | $247.99 | 7,600 | $1.9M | 7.6% |
| 8 | $249.04 | 8,905 | $2.2M | 9.0% |
| 9 | $249.04 | 8,905 | $2.2M | 9.0% |
| 10 | $249.97 | 12,578 | $3.1M | 12.8% |
| 11 | $249.97 | 12,578 | $3.1M | 12.8% |
| 12 | $251.00 | 2,300 | $577K | 2.3% |
| 13 | $252.24 | 3,299 | $832K | 3.4% |
| 14 | $252.24 | 3,299 | $832K | 3.4% |
| 15 | $253.21 | 1,100 | $279K | 1.1% |
| 16 | $254.10 | 1,300 | $330K | 1.3% |
| 17 | $255.02 | 2,400 | $612K | 2.5% |
| 18 | $256.10 | 500 | $128K | 0.5% |
| 19 | $256.10 | 500 | $128K | 0.5% |
| Total | $249.02 avg | 98,980 | $24.6M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |